Start:
November 2015
End:
June 2019
Enrollment:
60
This study will evaluate changes in the protein tau in the brain of people at different stages of Alzheimer's disease and in healthy volunteers. Tau deposition, which is seen in the brain of people with Alzheimer's or some other dementias, will be measured in a series of four brain scans using the imaging agent [18F]MNI-798.
Minimum Age: 50 Years
Maximum Age: 80 Years
Contact study personnel listed either under the general study contact or the location nearest you.
Who Is the General Study Contact?
For more information about this trial or the study sites, please call 1-888-662-6728 or email global.rochegenentechtrials@roche.com.
Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.
Lead: Molecular NeuroImaging
Collaborator Sponsor
Source: ClinicalTrials.gov ID: NCT02640092
An official website of the U.S. government, managed by the National Institute on Aging at the National Institutes of Health